6.5.2026 12:30:06 CEST | Demant A/S |
Investor Nyheder
Investor news
6. maj 2026
Udvidelse af Demants Executive Leadership Team
Ny President for Hearing Aids og medlem af Demants Executive Leadership TeamSøren Nielsen vil fremover have fuldt fokus på sin rolle som koncernchef & adm. direktør for Demant
Den 1. juni 2026 tiltræder Bassel Rifai som President for forretningsområdet Hearing Aids i Demant og indtræder samtidig i Executive Leadership Team, hvor han vil bidrage til at drive Demants strategi.
Som led i denne ændring træder Søren Nielsen ud af sin rolle som President for Hearing Aids for fremover at fokusere fuldt ud på sine opgaver som koncernchef & adm. direktør for Demant. Siden sin tiltrædelse som koncernchef for Demant i 2017 har Søren Nielsen sideløbende varetaget rollen som President for Hearing Aids. I denne periode har Demant næsten fordoblet sin størrelse. Denne udvikling understøtter et styrket fokus på den fortsatte eksekvering af koncernens strategi. Den afspejler også det betydelige potentiale for yderligere værdiskabelse og samarbejde på tværs af forretningsområder understøttet af Søren Nielsens indgående kendskab til industrien, når han fremover vil fokusere fuldt ud på koncernens overordnede strategi og resultater.
“Jeg er glad for at byde Bassel Rifai velkommen som ny President for Hearing Aids og medlem af Demants Executive Leadership Team. Bassel kommer med en stærk kombination af strategisk forståelse, en ingeniørmæssig baggrund og solid kommerciel ledelseserfaring inden for medicoindustrien. Med sin grundlæggende forståelse for life-science markeder er jeg overbevist om, at Bassel, i samarbejde med ledelsen i Hearing Aids og tusindvis af engagerede og dedikerede kolleger verden over, er den rette profil til at sikre, at vores Hearing Aids-forretning fortsat leverer førende innovation og vækst,” siger Søren Nielsen, koncernchef & administrerende direktør for Demant.
I forbindelse med annonceringen udtaler Bassel Rifai: “Jeg glæder mig til at blive en del af Demant på et vigtigt tidspunkt i virksomhedens positive udvikling. Selskabet har en stolt 120-årig historie og en imponerende track record inden for innovation, vækst og et fortsat stort potentiale for at hjælpe høretab. Jeg er inspireret af virksomhedens formål om at forbedre livskvaliteten for mennesker med høretab, og jeg ser frem til at stå i spidsen for Hearing Aids-organisationen med henblik på at styrke vores markedsposition og skabe meningsfulde resultater for brugere og kunder.”
Bassel Rifai har tilbragt størstedelen af sin karriere i internationale medicovirksomheder. Senest har han været EVP & President for EMEA & APAC hos Ambu. Tidligere har han haft en række ledende stillinger hos Johnson & Johnson i globale, amerikanske og europæiske roller inden for marketing, ledelse og salg. Forinden arbejdede han med management consulting hos McKinsey & Company. Bassel har desuden en ph.d. i Biomedical Engineering fra University of Oxford samt en bachelorgrad i Electrical Engineering fra UCLA.
Curriculum vitae
2021 – i dag: Ambu
EVP & President, EMEA & APAC
SVP Chief Marketing Officer
2014 – 2021: Johnson & Johnson
Vice President, Global & US Marketing – Spine
General Manager – US Osteo-biologics
Sales Director – UK Orthopedics
Director – Orthopedics EMEA
2011 – 2014: McKinsey & Company
Engagement Manager – Healthcare
Yderligere information:
Søren Nielsen, koncernchef & adm. direktør
Tlf. +45 3917 7300
www.demant.com
Øvrige kontaktpersoner:
René Schneider, CFO
Peter Pudselykke, Head of Investor Relations
Gustav Høegh, Investor Relations Officer
Maribel Alonso Francisco, Communication Manager
Kontakter
Maribel Alonso Francisco, Communication Manager, +45 3171 9261, msbl@demant.com
Om Demant A/S
Demant is a world-leading hearing healthcare group that offers innovative technologies, solutions and expertise to help people hear better. In every aspect, from hearing care and hearing aids to diagnostic equipment and services, Demant is active and engaged. Headquartered in Denmark, the Group employs more than 26,000 people globally and is present with solutions in 130 countries creating life-changing differences through hearing health. William Demant Foundation holds the majority of shares in Demant A/S, which is listed on Nasdaq Copenhagen and among the 25 most traded stocks.
Vedhæftninger
Investor news – Udvidelse af Demants Executive Leadership Team.pdf
6.5.2026 12:30:06 CEST | Demant A/S |
Investor News
Investor news
6 May 2026
Expansion of Demant’s Executive Leadership Team
New President of Hearing Aids and member of Demant’s Executive Leadership Team Søren Nielsen to fully focus on his position as President & CEO of Demant
Effective 1 June 2026, Bassel Rifai will join Demant as President of the Hearing Aids business area and become a member of the Executive Leadership Team and thus take part in driving Demant’s strategy forward.
As part of this change, Søren Nielsen will step out of his role as President of Hearing Aids to focus fully on his position as President & CEO of the Demant Group. Since assuming the role of CEO of the Demant Group in 2017, Søren Nielsen has concurrently held the position as President of Hearing Aids. During this period, Demant almost doubled in size. This development supports a strengthened focus on the continued execution of the Group’s strategy and reflects the significant potential for further value creation and cross-business collaboration, enabled by Søren Nielsen’s industry knowledge, as he will now focus fully on the Group’s overall strategy and performance.
“I am pleased to welcome Bassel Rifai as the new President of Hearing Aids and member of Demant’s Executive Leadership Team. With a strategic mindset, Bassel brings a strong combination of a background in engineering and deep commercial leadership experience in medical technologies. With his in-depth understanding of healthcare markets, I am confident that Bassel, supported by the Hearing Aids leadership team and thousands of dedicated and passionate colleagues around the world, is the right profile to ensure that our Hearing Aids business continues to deliver industry-leading innovation and growth,” says Søren Nielsen, President & CEO of Demant.
Commenting on his new role, Bassel Rifai says: “I’m very excited to join Demant at an important point in its growth journey. The company has a proud 120-year legacy and impressive track record of innovation and growth, with even more potential ahead to address hearing loss. I am inspired by the company’s purpose, to create life-changing differences through hearing health. And I look forward to leading the Hearing Aids organisation to advance our market position and deliver meaningful outcomes for users and customers.”
Bassel Rifai has spent the majority of his career in international medical technology companies. Most recently, he served as EVP & President of EMEA & APAC at Ambu. Prior to that, he held senior leadership positions at Johnson & Johnson in global, US, and European roles, across marketing, general management and sales. Before that, he worked in management consulting at McKinsey & Company. Bassel holds a PhD in Biomedical Engineering from the University of Oxford and a Bachelor of Science in Electrical Engineering from UCLA.
Curriculum vitae – Bassel Rifai
2021 – now: Ambu
EVP & President EMEA & APAC
SVP Chief Marketing Officer
2014 – 2021: Johnson & Johnson
Vice President, Global & US Marketing – Spine
General Manager – US Osteo-biologics
Sales Director – UK Orthopedics
Director – Orthopedics EMEA
2011 – 2014: McKinsey & Company
Engagement Manager – Healthcare
Further information:
Søren Nielsen, President & CEO
Phone +45 3917 7300
www.demant.com
Other contacts:
René Schneider, CFO
Peter Pudselykke, Head of Investor Relations
Gustav Høegh, Investor Relations Officer
Maribel Alonso Francisco, Communication Manager
Contacts
Maribel Alonso Francisco, Communication Manager, +45 3171 9261, msbl@demant.com
About Demant A/S
Demant is a world-leading hearing healthcare group that offers innovative technologies, solutions and expertise to help people hear better. In every aspect, from hearing care and hearing aids to diagnostic equipment and services, Demant is active and engaged. Headquartered in Denmark, the Group employs more than 26,000 people globally and is present with solutions in 130 countries creating life-changing differences through hearing health. William Demant Foundation holds the majority of shares in Demant A/S, which is listed on Nasdaq Copenhagen and among the 25 most traded stocks.
Attachments
Investor news – Expansion of Demant’s Executive Leadership Team.pdf
